Biomanufacturing for both traditional biologics and new modalities, such as cell and gene therapies, continues to be an active area of investment for CDMOs/CMOS. Some of...
US scientific services supplier Thermo Fisher Scientific is investing $82.5 million to expand operations and create 169 jobs at its biologic drug substance manufacturing...
As it ramps up production on three continents, US Covid-19 vaccine manufacturer Moderna is expanding its collaborations with CDMO suppliers in Europe, the US and Asia. At...
US laboratory equipment maker Thermo Fisher Scientific has agreed to buy compatriot firm PPD, a contract research company for the pharma and biotech industry, for $17.4...
Thermo Fisher Scientific plans to spend more than $600 million to upgrade its bioprocessing operations up to 2022. It aims to more than double current manufacturing...
In another move to boost its position in diagnostics for Covid-19 and other infectious diseases, Thermo Fisher Scientific has signed a definitive agreement to acquire...
To support worldwide development of Covid-19 drugs and vaccines, CDMO Thermo Fisher Scientific is investing in new facilities for its cell and gene therapy portfolio in...
US scientific equipment manufacturer Thermo Fisher Scientific and China-based CDMO Innoforce have formed a joint venture to own and operate a new pharma services facility...
